Literature DB >> 10854750

Expression of PSD-95/SAP90 is critical for N-methyl-D-aspartate receptor-mediated thermal hyperalgesia in the spinal cord.

Y X Tao1, Y Z Huang, L Mei, R A Johns.   

Abstract

PSD-95/SAP90, a molecular scaffold protein, attaches the N-methyl-D-aspartate receptor to cellular signaling pathways through PSD-95/DLG/Z0-1 domain interactions at neuronal synapses.(5,9) This suggests that PSD-95/SAP90 might be involved in many physiological and pathophysiological actions triggered via the N-methyl-D-aspartate receptor in the central nervous system. Here, we present evidence that suppression of the expression of PSD-95/SAP90 in the spinal cord significantly attenuated facilitation of the tail-flick reflex triggered through N-methyl-D-aspartate receptor activation but not baseline tail-flick reflex latency. Moreover, PSD-95/SAP90's messenger RNA and protein were enriched in the spinal cord and selectively distributed in the superficial dorsal horn, where PSD-95/SAP90 overlapped with the N-methyl-D-aspartate receptor. In spinal cord neurons, PSD-95/SAP90 interacted with the N-methyl-D-aspartate receptor subunits 2A/2B. It is indicated that activation of the N-methyl-D-aspartate receptor in spinal hyperalgesia results in association of the N-methyl-D-aspartate receptor with PSD-95/SAP90 and that PSD-95/SAP90 is required for noxious thermal hyperalgesia triggered via the N-methyl-D-aspartate receptor at the spinal cord level. The present findings may provide novel insights into the mechanisms for persistent sensitization of the somatosensory system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854750     DOI: 10.1016/s0306-4522(00)00193-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

1.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment.

Authors:  Yuan-Xiang Tao; Roger A Johns
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 3.  Ionotropic glutamate receptors in spinal nociceptive processing.

Authors:  Max Larsson
Journal:  Mol Neurobiol       Date:  2009-10-31       Impact factor: 5.590

Review 4.  Modulation of nociceptive ion channels and receptors via protein-protein interactions: implications for pain relief.

Authors:  Tom Rouwette; Luca Avenali; Julia Sondermann; Pratibha Narayanan; David Gomez-Varela; Manuela Schmidt
Journal:  Channels (Austin)       Date:  2015-06-03       Impact factor: 2.581

5.  Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain.

Authors:  Weihua Cai; Shaogen Wu; Zhiqiang Pan; Jifang Xiao; Fei Li; Jing Cao; Weidong Zang; Yuan-Xiang Tao
Journal:  Neuropharmacology       Date:  2018-09-05       Impact factor: 5.250

6.  Neuronal plasticity in the cingulate cortex of rats following esophageal acid exposure in early life.

Authors:  Banani Banerjee; Bidyut K Medda; Jamie Schmidt; Ivan M Lang; Jyoti N Sengupta; Reza Shaker
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

7.  Spinal cord NMDA receptor-mediated activation of mammalian target of rapamycin is required for the development and maintenance of bone cancer-induced pain hypersensitivities in rats.

Authors:  Ming-Hung Shih; Sheng-Chin Kao; Wei Wang; Myron Yaster; Yuan-Xiang Tao
Journal:  J Pain       Date:  2012-02-15       Impact factor: 5.820

8.  Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.

Authors:  Wei Guo; Feng Wei; Shiping Zou; Meredith T Robbins; Shinichi Sugiyo; Tetsuya Ikeda; Jian-Cheng Tu; Paul F Worley; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

9.  Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice.

Authors:  Feng Tao; Qingning Su; Roger A Johns
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

Review 10.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.